Lymphoma, Marginal Zone
2 clinical trials · Condition
◉ Watch Lymphoma, Marginal Zone
| Record | Firm | Date |
|---|---|---|
| Study of TRPH-222 in Patients With Relapsed and/or Refractory B-Cell Lymphoma (NCT03682796) | Triphase Research and Development III Corp. | 2018-10-15 |
| Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL) (NCT02669017) | ADC Therapeutics S.A. | 2016-03-01 |
Track Lymphoma, Marginal Zone automatically
Every clearance here is in the API, with alerts when new ones post.